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Humanpresequence protease (hPreP) is anM16met-
alloprotease localized in mitochondria. There, hPreP
facilitates proteostasis by utilizing an 13,300-A˚3
catalytic chamber to degrade a diverse array of
potentially toxic peptides, including mitochondrial
presequences and b-amyloid (Ab), the latter of which
contributes to Alzheimer disease pathogenesis.
Here, we report crystal structures for hPreP alone
and in complex with Ab, which show that hPreP
uses size exclusion and charge complementation
for substrate recognition. These structures also
reveal hPreP-specific features that permit a diverse
array of peptides, with distinct distributions of
charged and hydrophobic residues, to be specifically
captured, cleaved, and have their amyloidogenic
features destroyed. SAXS analysis demonstrates
that hPreP in solution exists in dynamic equilibrium
between closed and open states, with the former
being preferred. Furthermore, Ab binding induces
the closed state and hPreP dimerization. Together,
these data reveal the molecular basis for flexible
yet specific substrate recognition and degradation
by hPreP.
INTRODUCTION
Throughout all domains of life, regulated proteolysis ameliorates
the effects of protein damage, misfolding, and aggregation
(Powers et al., 2009). Unlike canonical protein-protease net-
works, M16 metalloproteases, which are Zn2+-dependent and
ATP-independent, do not select substrates on the basis of
posttranslational modifications or embedded degradation tags
(Malito et al., 2008; Ravid and Hochstrasser, 2008; Sauer and
Baker, 2011). These proteases are vital to an array of biological
processes, including the clearance of insulin and other peptide
hormones by human insulin-degrading enzyme (IDE) (Guo
et al., 2010), the removal of targeting peptides from preproteins
by themitochondrial processing peptidase (MPP, also a compo-996 Structure 22, 996–1007, July 8, 2014 ª2014 Elsevier Ltd All rightnent of the cytochrome bc1 complex in plants) (Taylor et al.,
2001; Xia et al., 1997), and the catabolism of hemoglobin by
falcilysin (Fln) in the malaria parasite (Murata and Goldberg,
2003). Structural studies revealed that M16 proteases share a
conserved architecture of two homologous, 50-kDa domains
enclosing a large catalytic chamber. Three families, M16A–C,
have been characterized on the basis of the connection between
these two domains. In M16A, a short loop connects the two do-
mains (Shen et al., 2006), whereas an extended helical linker
joins them in M16C (Johnson et al., 2006). M16B proteases
lack a linker because the two subunits arise from distinct genes
(Taylor et al., 2001) (Figure 1A). Because several M16 substrates,
e.g. insulin and amyloid-b (Ab), are involved in the pathogenesis
of human disease, dissecting the operating logic of M16 prote-
ases has been a subject of numerous investigations (Falkevall
et al., 2006; Manolopoulou et al., 2009).
Human presequence protease (hPreP) is a 117-kDa M16C
enzyme that is widely expressed in human tissues (Mzhavia
et al., 1999). HPreP primarily localizes to the mitochondrial
matrix, where it cuts an array of peptides into recyclable frag-
ments (Alikhani et al., 2011a; Chow et al., 2009; Falkevall et al.,
2006). Its substrates include N-terminal mitochondrial targeting
peptides or presequences, the clearance of which is vital to pro-
teostasis because these peptides can insert into mitochondrial
membranes, disrupting their electrical potential and uncoupling
respiration (Koppen and Langer, 2007; Mossmann et al., 2012).
Consistent with this idea, double knockout of A. thaliana PreP
(atPreP) 1 and 2 results in a delayed growth phenotype, whereas
yeast PreP deletions display impaired growth on a nonferment-
able carbon source under aerobic conditions (Kambacheld
et al., 2005; Nilsson Cederholm et al., 2009). Substrate recogni-
tion and degradation by PrePs is modeled from the closed-state
structure of atPreP, which uses a negatively charged catalytic
chamber to engulf substrate peptides of up to 65 residues
while excluding larger, folded proteins (Falkevall et al., 2006;
Johnson et al., 2006; Sta˚hl et al., 2005). Within the chamber, a
copurified peptide was observed, revealing that catalysis re-
quires the close apposition of conserved residues on both the
N and C domains. In the closed state, substrates cannot enter
the catalytic chamber, and reaction products cannot exit. How-
ever, the nature of the conformational switch(es) that PrePs
undergo to permit substrate capture is not well understood.
HPreP’s architecture is expected to be similar to atPreP baseds reserved
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Figure 1. Conserved Mechanisms for Substrate Capture by hPreP
(A) M16 metalloprotease domain organization.
(B) Crystal structure of hPreP.
(C) Volumetric analysis of the hPreP catalytic chamber performed with 3V (Voss and Gerstein, 2010).
(D) Electrostatic surface representations of the hPreP, atPreP (Protein Data Bank ID code 2FGE), and Fln (PDB ID code 3S5H) catalytic chambers at ± 6 kT/e
performed with APBS (Baker et al., 2001). Positive surfaces are blue, negative ones red, and neutral ones white.
(E) Analysis of M16C catalytic chamber conservation performed with ConSurf (Ashkenazy et al., 2010). Positions are colored on a sliding scale from magenta
(most conserved) to teal (degenerate).
See also Figures S1 and S2.
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Table 1. Data Collection and Refinement Statistics
Crystal hPreP E107Q hPreP E107Q + Ab40
PDB ID code 4L3T 4NGE
Data Collection
Beamline APS 19ID APS 19ID
Wavelength (A˚) 0.97895 1.045
Space group C2 C2
Unit Cell Parameters
a, b, c (A˚) 245.8, 85.1, 158.5 247.3, 86.2, 158.6
a, b, g () 90, 127.5, 90 90, 127.6, 90
Molecules in ASU 2 2
Resolution (A˚) 50–2.03 50–2.70
Rsym (%)
a 8.6 (58.5)b 18.0 (59.7)
I/s 17.1 (2.8) 8.59 (1.8)
Redundancyc 4.1 (3.8) 2.9 (2.4)
Completeness 98.2 (97.0) 99.1 (98.2)
Unique reflections 163,827 (8,053) 71,876 (3,557)
Heavy atom sites 54 5
Figure of merit 0.83 0.82
Refinement
Rwork (%)
d 17.1 19.1
Rfree (%)
e 21.0 23.2
RMS Deviations
Bond lengths (A˚) 0.012 0.004
Bond angles () 0.99 0.85
Number of
Protein atoms 15,892 15,986
Solvent molecules 1154 68
Metal cofactors 2 2
Ramachandran plot (%)
Preferred region 98.17 97.09
Allowed region 1.83 2.91
Disallowed region 0 0
B-factors (A˚2)
Protein 35.3 44.5
Solvent 46.4 49.6
aRsym = Sjj < I >  IjjS < I > , where Ij is the intensity of the jth reflection
and < I > is the average intensity.
bValues in parentheses indicate the outer resolution shell.
cNobs/Nunique.
dRwork = ShkljFobs – Fcalcj / ShkljFobsj.
eRfree calculated as Rwork but on 5% data excluded from refinement.
Structure
Structures and Conformations of Human PrePon 27% sequence identity. However, hPreP functions in radically
different biological contexts from atPreP and, correspondingly,
has distinct substrate cleavage patterns. Thus, hPreP likely
employs a distinct set of substrate recognition and degradation
principles (Chow et al., 2009; Johnson et al., 2006; Malito et al.,
2008).
Intriguingly, hPreP degrades several functionally relevant Ab
species (Ab40, Ab42, and AbArctic) that are generated by b- and
g-secretase cleavage of the amyloid precursor protein (Falkevall
et al., 2006). Ab aggregates are toxic to the neuron and play a key
role in Alzheimer’s disease (AD) pathogenesis through intra- and998 Structure 22, 996–1007, July 8, 2014 ª2014 Elsevier Ltd All rightextracellular signaling pathways. Mutations in Ab production
pathways, e.g. at g-secretase and amyloid precursor protein
loci, can lead to Ab accumulation and familial AD (Huang and
Mucke, 2012; Yankner and Lu, 2009). Defects in Ab clearance
pathways may be important to both familial and sporadic or
late-onset AD (Malito et al., 2008; Saido and Leissring, 2012).
Joint action of proteases, including IDE, neprilysin, and
cathepsin B, clears Ab from the extracellular matrix, cytosol,
ER, Golgi, endosomes, and lysosomes (Farris et al., 2003; Iwata
et al., 2001; Mueller-Steiner et al., 2006). Recent studies indicate
that hPreP is the Ab-degrading protease in mitochondria (Ali-
khani et al., 2011b; Falkevall et al., 2006; Pinho et al., 2010).
Immunodepletion of hPreP in human brain mitochondria pre-
vents degradation of mitochondrial Ab. Additionally, hPreP activ-
ity is diminished in AD brains compared with age-matched
controls. Mitochondrial lesions are implicated in AD pathogen-
esis, and mitochondria may be sites of Ab accumulation and
toxicity through inhibition of Ab-binding alcohol dehydrogenase
and increased production of reactive oxygen species (Lustbader
et al., 2004; Manczak et al., 2006). These data suggest that a
molecular appreciation of hPreP’s operating logic can increase
our understanding of AD pathogenesis.
Although IDE uses its catalytic chamber to specifically recog-
nize and cleave amyloidogenic peptides, the molecular basis for
Ab destruction by hPreP remains elusive. Here we describe the
crystal structure of hPreP, which reveals that size exclusion
and charge complementation are key principles for substrate
capture and identifies those residues within the catalytic cham-
ber used for recognition of diverse peptide motifs. We further
show that the dynamics of substrate capture are modulated by
the enzyme’s linker region. Crystallographic and mass spec-
trometry (MS) analyses reveal how hPreP specifically binds Ab
by relaxing the requirement for a defined orientation of the pep-
tide in the catalytic cleft and using both a hydrophobic exosite
and S1 pocket to recognize and degrade Ab in a selective, non-
processive manner. Finally, small-angle X-ray scattering (SAXS)
analysis reveals the nature of the closed-to-open conformational
switch that permits substrate entry into the catalytic chamber
and shows that substrate binding can induce domain closure
and dimerization. Together, these data reveal the mechanisms
hPreP employs for recognition and degradation of amyloido-
genic peptides.
RESULTS AND DISCUSSION
Crystal Structure of hPreP
To elucidate themolecular basis for hPreP substrate recognition,
we determined the crystal structure for isoform 1 of substrate-
free hPreP in a closed conformation at 2.0 A˚ (Figure 1B; Table 1).
Two key modifications were required to obtain diffracting
crystals: surface lysine methylation, which reduced catalytic ac-
tivity but did not impact protein purity, and introduction of an
active site E107Q substitution, which renders hPreP catalytically
inactive but substrate-binding competent (Figure S1 available
online) (Johnson et al., 2006; Rypniewski et al., 1993). Iodine-
based single-wavelength anomalous dispersion (SAD) phases
were crucial for removing the phase bias of the initial molecular
replacement (MR) solution and drastically improved the electron
density map in key regions, e.g. the hPreP linker, that weres reserved
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Structures and Conformations of Human PrePotherwise disordered (Figure S2) (Abendroth et al., 2011). Dis-
playing an overall architecture that is highly conserved across
the M16C family, hPreP is composed of the hPreP-N (amino
acids [aa] 33–509) and hPreP-C (aa 576–1037) domains, which
are connected by an extended helical hairpin (aa 510–575).
HPreP-N and hPreP-C can be further broken down into topolog-
ically similar D1–D4 (Figure 1B). Although D1–D4 superimpose
poorly onto one another, pairs D1 (aa 33–288) and D3 (aa 576–
844) (root-mean-square deviation [rmsd] = 3.9 A˚ for 862 atom
pairs) and D1 and D4 (aa 855–1037) (rmsd = 4.2 A˚ for 732
atom pairs) superimpose best onto one another. The other
four pairwise comparisons yield rmsds greater than 5.1 A˚. This
is consistent with ancient gene duplication that used D1 as a
template for hPreP-C.
The hPreP structure demonstrates that substrate selection by
size exclusion is a conserved mechanism of M16C proteases.
HPreP-N and HPreP-C enclose a large, 13,300-A˚3 chamber
for engulfing substrates (Figure 1C). Formation of the active
site requires the close apposition of hPreP-N and HpreP-C,
whereby the inverted zinc-bindingmotif on D1 (H104XXEH.E205)
and residues R900 and Y906 on D4 form a cleft within the cham-
ber for substrate binding and catalysis (Figure S2) (Johnson
et al., 2006). Because there is no portal for substrate access in
this conformation, substrates too large to fit into the enclosed
chamber are excluded on the basis of their size. Available
M16C structures, atPreP and Fln, have similarly sized chambers
(13,000 A˚3 and 12,500 A˚3, respectively), indicating that the
upper limit for substrate size determined for atPreP, 65 resi-
dues, is conserved across species (Figure S2) (Moberg et al.,
2003; Sta˚hl et al., 2005).
Electrostatic interactions play a key role in M16 substrate cap-
ture (Johnson et al., 2006; Manolopoulou et al., 2009; Ralat et al.,
2011). Interestingly, we observed that, although the N halves of
M16C chambers are uniformly negatively charged, the C halves
are variably charged between species (Figure 1D). The surface
of Fln-C is mostly positively charged. HPreP-C has a weakly
and variably charged surface, whereas atPreP-C contains a
negatively charged pocket surrounded by a weakly positive sur-
face. Furthermore, PreP-N is composed of highly conserved res-
idues, whereas PreP-C is largely degenerate except for those
residues that contribute to the catalytic cleft or form contacts
with hPreP-N (Figure 1E). These data support a model for
substrate selection by unipolar charge complementation be-
tween hPreP-N and substrates. The unique charge distribution
in hPreP’s catalytic chamber may explain why hPreP fails to
degrade intact insulin because hPreP-C lacks a positively
charged surface to trap negatively charged insulin in the cham-
ber (Falkevall et al., 2006; Manolopoulou et al., 2009).
Topography of the Catalytic Chamber
Characteristics of the hPreP catalytic chamber provide a struc-
tural basis for the protease’s observed substrate degradation
patterns (Figure 2A) (Chow et al., 2009). The hPreP-N chamber
contains two deep pockets near the active site (Figure 2B). A hy-
drophobic pocket, consisting of L111, F123, F124, and L127,
forms an S1 or S
0
1 site immediately adjacent to the active site,
which explains the preference for bulky hydrophobic residues
immediately adjacent to the scissile bond. A second, basic
pocket comprised of R888 and H896, 12–16 A˚ away from theStructure 22,catalytic zinc, can bind substrate C termini via salt bridges (Fig-
ure 2B). The existence of these pockets explains why cleavage
sites with hydrophobic residues in the P1 or P
0
1 positions can
be found two to five residues from the C terminus (Chow et al.,
2009; Falkevall et al., 2006). Furthermore, this explains why,
despite a high degree of architectural similarity (Figure S2),
hPreP has distinct substrate preferences from atPreP, which
uses an acidic S
0
1 pocket to bind basic residues in the P
0
1 posi-
tion (Johnson et al., 2006; Sta˚hl et al., 2005). These features of
hPreP’s catalytic cleft may also explain how hPreP effectively
degrades peptides as small as leu-enkephalin, a pentapeptide,
whereas the minimal substrate length for atPreP is proposed to
be 11 residues (Chow et al., 2009; Sta˚hl et al., 2005).
Presequences are diverse in sequence but have similar phys-
iochemical properties in that they are enriched in positively
charged and hydrophobic residues segregated on opposite
faces of amphipathic a helices (Moberg et al., 2004). In the hPreP
chamber, residues D716, D212, E214, and D377 form a contig-
uous, negatively charged surface 15–19 A˚ away from the active
site (Figure 2C). Not only would these residues contribute to
attracting positively charged residues in presequences, but
their arrangement also explains why hPreP prefers arginines
three to five residues distal to the scissile bond (Chow et al.,
2009). Hydrophobic clusters are also present inside the hPreP-N
chamber. These include those formed by L60, F443, M446, and
L447; by Y380, Y383, and Y450; and by F344, L348, L428, and
I432 (Figure 2D). The presence of these residues suggests that
hydrophobic surfaces facilitate the recognition of substrates
diverse with respect to the precise location of hydrophobic
residues.
Mutational Analysis of the Linker Region
An extended helical hairpin, originating in D2 and stretching
across the surface of hPreP to terminate in D3, is the distinguish-
ing structural feature of theM16C family (Figures 1A and 1B). The
importance of the linker for catalytic efficacy and allostery of IDE,
an M16A enzyme, is documented (McCord et al., 2013). The
PreP linker is likely involved in bringing PreP-N and PreP-C
into close apposition for efficient catalysis (Johnson et al.,
2006). To test this, we targeted P558 and L557. Both are highly
conserved and rest in a conserved hydrophobic pocket on D1
(Figure 3A; Figure S3). We generated mutations to assess the
importance of proline’s restricted dihedral freedom (P558G)
and of the hydrophobic pocket’s integrity (L557E) to catalysis.
We found that L557E and P558G exhibited 20 and 40% the
specific activity of WT hPreP, respectively (Figure 3B). Kinetic
analysis revealed that both mutants have a reduced Vmax and
that L557E has an increased KM (Figure 3C). A fluorescence ther-
mal shift confirmed that these effects are specific to hPreP
kinetics because mutants display melting curves and melting
temperature (Tm) values similar to the wild type (WT), ruling out
the possibility that mutants are simply destabilized (Figure S3).
These findings support a role for the linker in catalytic compe-
tency, likely by modulating the open-closed conformational
switch that is required for efficient catalysis.
MS Analysis of Ab Degradation by hPreP
Using Ab as a model substrate, we examined the sequence of
cleavage events that follows substrate capture to resolve996–1007, July 8, 2014 ª2014 Elsevier Ltd All rights reserved 999
Figure 2. Residues in the hPreP Chamber
Facilitate Substrate Recognition
(A) HPreP-N catalytic chamber.
(B) Two pockets (L111, F123, F124, and L127 as
well as H896 and R888) explain the observed
cleavage site preference for P1 or P
0
1 hydrophobic
residues and scissile bonds two to five residues
distal from substrate C termini.
(C) Labeled acidic residues are proximal to the
active site and can facilitate interaction with basic
substrate residues.
(D) A network of hydrophobic resides in hPreP-N
permits the capture of hydrophobic residues.
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Structures and Conformations of Human PrePwhether hPreP degrades substrates stochastically and whether
degradation proceeds along a defined path. Based on previous
liquid chromatography-tandemmass spectrometry (LC-MS/MS)
data, the cleavage sites of Ab40 by hPreP could occur after Q15,
K16, F19, F20, A30, G33, and L34 (Falkevall et al., 2006). How-
ever, a separate study identified cleavage sites to be restricted
to sites following F20 and L34 (Figure 4C) (Chow et al., 2009). Fal-
kevall et al. (2006) used prolonged incubation (1 hr), whereas
Chow et al. (2009) did not report precise experimental condi-
tions. To discriminate full-length Ab cleavage sites from those
that arise from subsequent cleavages of reaction products, we
quenched the Ab degradation reaction rapidly (1 s). Tandem
mass spectrometry (MS/MS) analyses of the resultant Ab40 frag-
ments using MALDI-TOF/TOF revealed that Ab1-20 is the single1000 Structure 22, 996–1007, July 8, 2014 ª2014 Elsevier Ltd All rights reservedmajor cleavage product, increasing in
abundance at higher hPreP concentra-
tions (Figure 4A; Table 2). A secondary
fragment, Ab1–19, became noticeable
only at high hPreP concentrations. How-
ever, we could not detect the corre-
sponding C-terminal Ab fragments. We
then turned to quadrupole TOF (Q-TOF)
LC-MS/MS to ensure the comprehensive
identification of degraded Ab fragments
with high mass accuracy. In these
spectra, Ab1–20 and Ab21–40 are the domi-
nant species observed and Ab20–40 the
minor one (Figure 4B; Table 2; Figure S2).
Thus, hPreP prefers to cut between F20
and A21, whereas cleavage between
F19 and F20 is a secondary cut site,
which reveals that Ab degradation by
hPreP is not a stochastic process. The
fact that we did not observe most of the
previously identified cleavage sites sug-
gests that these are used after Ab degra-
dation products are available to serve as
substrates (Figure 4C). From these data,
we deduce that Ab in the hPreP chamber
is cleaved once and that the resulting
products are subsequently released.
Thus, hPreP degrades Ab in a selective
manner that is not processive.
We also used our MS data to estimate
hPreP’s catalytic efficiency. Previously,the kcat for Ab degradation was estimated at 0.06 s1, with a
KM of 2 mM, using Ab as an alternate substrate inhibitor for
a fluorescent peptide (Chow et al., 2009). Surprisingly, our
Q-TOF data show that hPreP degrades Ab40 at a rate of
300 s1 (Figure 4B; Table S2). Our TOF-TOF data showed a
similarly high rate, 25–300 s1 across different hPreP concen-
trations (Figure S4; Table S2). This rate is 2–3 orders of
magnitude higher than reported previously (Chow et al., 2009),
suggesting that hPreP is a highly efficient protease.
Structure of hPreP in Complex with Ab
To elucidate the structural basis for specific hPreP recognition
and degradation of Ab, we determined the structure of the hPreP
E107Q-Ab40 complex at 2.70 A˚ by MR/SAD using the arsenic
Figure 3. Role of the Linker in Catalysis
(A) L557E and P558G sit in a conserved hydrophobic pocket on the D1 surface. The lower inset is colored by the electrostatic surface and the upper one by
conservation.
(B) Specific activities of hPrePWT andmutants at an enzyme concentration of 1.25 nM. Activity was determined bymonitoring the cleavage of 0.5 mMsubstrate V
at 37C.
(C)WT andmutant hPreP specific activities at indicated substrate V concentrations. Data sets were fit to theMichaelis-Menten equation, with Vmax (98, 29, 43 s
1)
and Km (26, 82, 26 mM) calculated for WT, L557E, and P558G, respectively. Mean ± SD represents at least three experiments.
See also Figure S3.
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Structures and Conformations of Human PrePmoiety of cacodylated cysteines as the heavy atom (Table 1; Fig-
ure S2) (Dyda et al., 1994). Ab, bound to the hPreP-N chamber
(Figure 5A), was visible by inspection of the initial MR/SAD solu-
tion and omit maps (Figure S5). We observed two bulky side
chains in the electron density immediately adjacent to the scis-
sile bond that, as revealed by our mass spectrometry data,
correspond to F19 and F20 (Figure 4; Figure S5). Based on this
assignment, we built the remaining visible Ab residues (Q15–
D23), which produced a good fit for the observed density (Fig-
ure 5D). The geometry of the active site is such that the peptidyl
bond between Ab F20 and A21 is ideally positioned for hPreP’s
catalytic base E107—whose ε1 and ε2 oxygens would be 5.0
and 4.0 A˚ away, respectively, based on the position of Q107—
to deprotonate a water molecule for nucleophilic attack on the
scissile bond (Figure 5D) (Johnson et al., 2006; Shen et al., 2006).
HPreP uses a trio of structural features to recognize Ab in the
catalytic cleft. First, hPreP binds Ab in an orientation opposite to
those observed previously in substrate-bound M16 structures
(Figure 5C) (Johnson et al., 2006; Shen et al., 2006; Taylor
et al., 2001). The relaxed requirement for substrate orientation
in the cleft demonstrates an unexpected degree of flexibility in
themanner in which hPreP binds substrates. Second, hydropho-
bic interactions coordinate substrates in the active site. A hydro-
phobic pocket formed by L111, F123, and F124 forms a highly
conserved S1 site for Ab F20 in the P1 position (Figures 1E,
5C, and 5D). Interestingly, hPreP repurposes R900 and Y906,
which were found to coordinate atPreP substrate backbone car-
bonyls and are required for efficient catalysis (Johnson et al.,
2006). R900 completes the S1 site through a cation-p interaction
with Ab F20, whereas Y906 forms a hydrogen bond with F20’s
backbone amine (Figures 5C and 5D). Finally, hPreP uses a b
strand (b7) to coordinate Ab in the cleft in a manner that specif-
ically impairs Ab’s ability to aggregate (Figure 5C). Although AbStructure 22,monomers are largely unstructured, structures of Ab fibrils
seeded from synthetic and human sources show that formation
of parallel, intermolecular b sheets involves the same amyloido-
genic segment of Ab, KVLFF, that we observe binding to
the hPreP catalytic cleft (Balbach et al., 2000; Lu et al., 2013;
Paravastu et al., 2008; Tjernberg et al., 1996). Thus, the
Ab-bound hPreP structure reveals that hPreP is specialized to
recognize and cleave the amyloidogenic segment of Ab that is
prone to form b sheets, thereby preventing Ab aggregation in
mitochondria.
Interestingly, we observed four unknown Ab residues binding
to a pocket on hPreP-N in both the MR/SAD solution and com-
posite omit maps (Figure 5A; Figure S5). We were unable to
resolve these residues’ side chains, which indicates that this
site anchors multiple Ab segments. The first of these residues
(x1) is separated by 9.5 A˚ (approximately three residues) from
the N terminus of the remaining three residues (y1–3) (Figure 5B).
A single bulky side chain is visible in the electron density protrud-
ing from y1 (Figure 5E), which is consistent with binding of bulky
hydrophobic residues from either the Ab N or C terminus (Fig-
ure 4C). Based on this area’s enrichment in hydrophobic resi-
dues (specifically L348, L428, I432, and F344 and L465, L60,
F443, L447, and Y450) and the presumptive orientation of the
Ab side chains toward them, we term it the ‘‘hydrophobic exo-
site.’’ This site is likely an evolutionarily recent development
because its conservation is relatively weak (Figure 1E). We pro-
pose that the hPreP exosite plays a role in anchoring larger pep-
tides (R40 residues) in the chamber, enabling their efficient
degradation (Manolopoulou et al., 2009; Ralat et al., 2011).
This hydrophobic clamp would confine the interaction of Ab
with hPreP, explaining why the primary cleavage site is between
Ab20 and Ab21. The existence of this site also offers an explana-
tion for how hPreP is able to efficiently capture Ab despite Ab996–1007, July 8, 2014 ª2014 Elsevier Ltd All rights reserved 1001
Figure 4. Mass Analysis of Ab Degradation
by hPreP
(A and B) MALDI-TOF/TOF (A) and deconvoluted
Q-TOF mass spectra (B) of Ab40 alone (lower
panel) and hPreP-degraded Ab40 (upper panels).
Ab40 and hPreP were mixed at the indicated molar
ratios (1:100–1000).
(C) Schematic of hPreP’s Ab40 cleavage sites.
Filled arrows denote sites identified by Falkevall
et al. (2006), whereas dashed arrows indicate
cleavage sites identified in this study. Asterisks
mark cleavage sites reported by Chow et al.
(2009).
See also Figure S4.
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Structures and Conformations of Human PrePcarrying a net negative charge (isoelectric point [PI] = 5.4) in the
mitochondrial matrix (pH 7.8) that would otherwise be repelled
by hPreP-N (Porcelli et al., 2005).
Conformational Profile of hPreP in Solution
To identify the nature of the conformational switch that permits
substrate capture and assess the effect of substrate binding
on hPreP dynamics, we analyzed the conformational statesTable 2. TOF-TOF and Q-TOF Mass Spectrometry Analysis of
hPreP-degraded Aba
TOF-TOF
Ab Mobs
b Mcalc
b Errorc b/y Ions
1–40 4,328.7 4,328.2 0.5 N/A
1–20 2,461.4 2,461.2 0.3 b5–9,b11–16, b18,b19,y7,
y8,y10,y12–20
1–19 2,314.4 2,314.1 0.3 b5–b8,b10–16, b18,y6,y7,
y11–19
Q-TOF
Ab Mobs Mcalc Error
d b/y Ions
1–40 4,327.117 4,327.148 7 b2,b6,b7,b9,b13–b15,b17,
b20–b27,b30–b35,b38, y1–
y6,y8–y9,y11,y18–y20, y23–
y25,y28–y33
1–20 2,460.094 2,460.161 27 b2,b5–b13,b15–b19, y1–y3,
y5,y7–y14,y17–y18
20–40 2,032.032 2,032.066 17 b2-b3,b5,b11–b20, y1–y2,
y6–y7,y9–y21
21–40 1,884.989 1,884.998 5 b2-b19,y1–y2,y3–y9, y11–
y16,y18–y20
aOutside Ab1–40, peaks that exist in Ab alone are not listed. Peaks that
match predicted Ab fragments but cannot be confirmed by MS/MS are
listed in Table S1.
b[M+H]+.
cError (in Da).
dError (in ppm) = ((Mobs  Mcalc) / Mcalc)(106)).
1002 Structure 22, 996–1007, July 8, 2014 ª2014 Elsevier Ltd All rights reservedof hPreP in solution with SAXS. The
observed radius of gyration (Rg) and
maximum diameter (Dmax) (33 and
117 A˚, respectively) for WT hPreP were
inconsistent with the parameters pre-
dicted for a population of closed-state
monomers (Rg = 31 A˚, Dmax = 108 A˚)or dimers (Rg = 46 A˚, Dmax = 149 A˚) (Figures 6A and 6B).
These findings agreed with the poor fit of theoretical scattering
curves for closed monomers (c = 3.2) and dimers (c = 18.6)
to the experimental data and the lack of intensity dip be-
tween 0.09–0.15 A˚1. Analysis of the hPreP E107Q yielded
similar results (Figures 6C and 6D), and we conclude that hPreP
does not exist exclusively as a closed monomer or dimer in
solution.
To directly assess the likelihood that hPreP populates multiple
states in solution, we modeled open hPreP conformations, sys-
tematically increasing the displacement between hPreP-N and
hPreP-C from 20 to 50 A˚, and assessed their ability to account
for the experimental data. We tested the ‘‘parallel spring,’’
‘‘hinge’’ (a D1/D4 pivot resembling the motion seen in M16A
pitrilysin), and ’’Open Book’’ (a D2/D3 pivot resembling the
motion seen in M16B MPP) motions (Figure S6) but found that
no single open state yielded a good fit (c < 2.0) to the data. We
found that the hinge motions reliably produced better fits to
the data than other types of motion with equivalent degrees of
opening (Figure S6). By testing mixtures of closed monomers,
dimers, and 20- to 50-A˚ hinge models, we were able to generate
an excellent fit to the WT data (c = 0.73), whose fractional occu-
pancy consisted of 72% closed monomers, 8% closed
dimers, 20% 40-A˚ hinges (Figures 6A and 6B; Figure S6). A
similar combination of states yielded the line of best fit for the
E107Q mutant, but we observed a higher propensity for closed
or partially closed states (Figures 6C and 6D). Together, these
data reveal that hPreP is predominantly a closed monomer,
which is consistent with our size exclusion data, with at least
one open state in solution (Figure S1). Given the resolution limit
for SAXS and the similarity of scattering curves for the 20-A˚
parallel spring, hinge, and open book (Figure S6) motions, the
precise nature of the movements underlying the open state(s)
of hPreP and their role in the hPreP catalytic cycle remain to
be determined.
We next assessed whether substrate binding could modify the
equilibrium between open and closed hPreP states in solution.
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Figure 5. Structural Basis of Ab Capture and
Recognition by HPreP
(A) Ab binding to hPreP-N.
(B) Hydrophobic exosite. Four Ab residues (x1 and
y1–3) are observed. Hydrophobic residues that
comprise the putative side chain binding pockets
are displayed in gray.
(C) Ab binding to the hPreP catalytic cleft. The S1
site consists of L111, F123, F124, and R900.
(D and E) 2Fo–Fc electron density maps contoured at
0.5 s for Ab residues bound to the catalytic cleft (D)
and the hydrophobic exosite (E). Arrows denote
preferred Ab cleavage sites by hPreP.
See also Figure S5.
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Structures and Conformations of Human PrePAnalysis of the scattering curve for the hPreP E107Q-Ab40 com-
plex revealed that the best fit to the data could be obtained using
a combination of monomers (83%) and dimers (17%) exclusively
in the closed state (c = 1.3) (Figures 6E and 6F; Figure S6). The fit
could not be improved with the addition of ‘‘open’’ states (Fig-
ure S6). The fraction of dimers observed in the substrate-bound
solution doubled compared with the WT, showing that substrate
binding can induce hPreP dimerization (Figures 6B and 6F).
These results agreed with the appearance of an intensity dip
from 0.09–0.15A˚1 in the experimental data (Figure 6F). Together
with the finding that domain closure occurs in the absence of
substrate (Figures 1B, 6A, and 6B), these results show that sub-
strate binding is sufficient, but not necessary, to induce domain
closure, the consequence of which is to lock the enzyme in a
catalytically competent state (Aleshin et al., 2009; Johnson
et al., 2006).Structure 22, 996–1007, July 8, 2014Comparison of hPreP and IDE
Although hPreP and IDE belong to distinct
M16 families, they have been considered
to be of the same functional class in terms
of their ability to recognize and degrade
amyloidogenic peptides (Aleshin et al.,
2009). The structures of hPreP alone and
in complex with Ab confirm that hPreP
and IDE both select substrates on the basis
of their size, shape, and charge distribu-
tion. Furthermore, both hPreP and IDE
target Ab amyloidogenicity for destruction.
However, the mechanism for Ab degrada-
tion by hPreP is dramatically different
from IDE. This difference may be due to
the distinct nature of their exosites. The
hPreP exosite recognizes a hydrophobic
patch of Ab or other substrate and acts in
concert with the catalytic cleft to constrain
cleavage sites. The hydrophobic exosite
likely binds unfolded peptide segments
because folded proteins usually do not
present flexible, hydrophobic surfaces for
capture. This would explain why hPreP
prefers to degrade structurally disordered
peptides (Falkevall et al., 2006). Conse-
quently, hPreP preferentially cuts Ab
at a specific site nonprocessively. Bycomparison, the IDE exosite anchors substrate N termini via
hydrogen bonds. This enables IDE substrates such as insulin,
TGF-a, and MIP-1a to retain a defined tertiary structure within
the chamber after capture. Because the unfolding of these
proteins within the IDE chamber is required to stabilize
the catalytic cleft, the cleavage of these peptides occurs
stochastically at a few predefined sites, and cleavage proceeds
processively (Guo et al., 2010; Manolopoulou et al., 2009;
McCord et al., 2013; Ren et al., 2010). Our data also indicate
that hPreP is 2- to 3-fold more efficient than IDE based on the
measured specific activities of 20 s1 versus 10 s1 for sub-
strate V and 25 s1 versus 8 s1 for Ab (Figure 3B) (Im et al.,
2007; McCord et al., 2013). This points toward the utility of
both hPreP and IDE as targets for controlling the Ab load in
AD patients. Finally, the oligomerization and conformations
of these two enzymes are distinct. HPreP is predominatelyª2014 Elsevier Ltd All rights reserved 1003
A B
C D
E F
Figure 6. Conformational Profiles of hPreP
in Solution
Pair distribution functions and scattering curves
for WT (A and B), E107Q (C and D), and E107Q and
Ab (E and F). Curve fitting was performed based on
atomic model input to CRYSOL (single models)
and OLIGOMER (multiple models). The volume
fractions shown below the profiles indicate the
percent composition by the conformational state
in solution that yielded the line of best fit for the
observed data (mixture). Exp., experimental.
See also Figure S6.
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Structures and Conformations of Human PrePmonomeric and closed, whereas IDE is a dimer that pre-
dominantly occupies open states in solution (McCord et al.,
2013). Thus, hPreP and IDE likely target distinct sets of sub-
strates in vivo, and hPreP should not be considered to be
mitochondrial IDE.Conclusions
The biology of hPreP is poorly understood. However, high-
throughput proteomics approaches indicate that hPreP un-
dergoes posttranslational modification by phosphorylation and
participates in protein-protein interactions with key compo-
nents of the citric acid cycle (Havugimana et al., 2012; Olsen
et al., 2010), either or both of which could enhance the clear-
ance of toxic peptides that impair mitochondrial function.
Here we developed a molecular picture of hPreP substrate
recognition and degradation that provides the structural context
for future studies to unravel the roles of hPreP in health and
disease. These data reveal how hPreP’s molecular features
enable it to effectively recognize and degrade substrates in a
manner that is flexible, eschewing strict requirements for sub-
strate size, sequence, and physiochemical profile, yet specific,
utilizing defined structural features to destroy amyloidogenic
peptides.1004 Structure 22, 996–1007, July 8, 2014 ª2014 Elsevier Ltd All rights reservedEXPERIMENTAL PROCEDURES
HPreP Cloning, Expression, and
Purification
HPreP cDNA was acquired from the Human
ORFeome (Open Biosystems) and subcloned into
an E. coli expression vector, pProEx, replacing its
mitochondrial targeting sequence (aa 1–33) with
an N-terminal - hexahistidine tag, which we refer
to as WT. HPreP mutations were generated from
this template using a Stratagene QuikChange site-
directed mutagenesis kit and verified by sequenc-
ing. HPreP WT and E107Q were expressed in
Rosetta(DE3) E. coli at 25C with 300 mM isopropyl
b-D-thiogalactopyranoside (IPTG) induction for
20 hr. HPreP mutants were induced with 30 mM
IPTG for 8 hr at 20C (Figures S1 and S3). Proteins
were thenpurifiedover nickel-nitrilotriacetic acidaf-
finity, SourceQ anion exchange, andSuperdex 200
gel filtration columns. Purified samples were flash-
frozen in liquid nitrogen and stored at80C. Sam-
ple purity was assessed by SDS-PAGE (Figure S1).
Synthetic Ab40 Production
Ab40 was synthesized at a 0.25-mmol scale
using fluorenylmethyloxycarbonyl chloride andN,N,N0N0-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate/
hydroxybenzotriazole chemistry on an Applied Biosystems 433A instrument.
To increase peptide solubility and facilitate purification, we used a modified
version of the method used by Sohma et al. (2004) as described in the Supple-
mental Experimental Procedures. Ab40 was purified by reverse phase high-per-
formance liquid chromatography, lyophilized, andstoredat20Cunder argon.
Protein Crystallization
To generate hPreP crystals, hPreP E107Q was subjected to reductive surface
lysine methylation (KMe) after anion exchanger or gel filtration (Rypniewski
et al., 1993) and then purified further by gel filtration. The initial condition
was identified from high-throughput crystallization screens using commer-
cially available kits and the Mosquito platform. Crystals were optimized for
diffraction by precipitant, pH, buffer, and additive screening (Figure S1).
Crystals were grown at 18C by hanging drop vapor diffusion by combining
6 mg/ml KMe hPreP-E107Q in buffer containing 20 mM HEPES (pH 7.5),
250 mM NaCl, and 2 mM dithiothreitol, with the mother liquor containing
15.2% (w/v) polyethylene glycol 8,000, 15 mM Tris(2-carboxyethyl)phosphine,
80 mM sodium cacodylate (pH 6.5), 160 mM calcium acetate, and 20% (v/v)
glycerol in a 1:1 (v/v) ratio. Within a week, crystals reached maximal size,
0.1 mm in the longest dimension. To obtain the hPreP-Ab complex, KMe
hPreP E107Q was incubated with a 5 molar excess of Ab40 for 1 hour at
18C, purified further by gel filtration, and crystallized as described above.
Data Collection and Structure Determination
Crystals were cryoprotected inmother liquor containing 30% (v/v) glycerol and
then flash-frozen in liquid nitrogen. Diffraction data were collected at beamline
Structure
Structures and Conformations of Human PreP19ID at Argonne National Laboratory and processed using HKL3000 (Minor
et al., 2006). A low-quality initial map (Rfree = 48%) was obtained using a ho-
mology model of hPreP generated by I-TASSER (Roy et al., 2010) as a molec-
ular replacement search model, followed by executing autobuild in PHENIX
(Adams et al., 2010). The electron density map and refinement statistics
were improved considerably by combining the phase information from MR
with that derived from SAD using iodide as the heavy atom after briefly soaking
the crystals in 200 mM potassium iodide for <30 s (Table 1; Figure S2). By in-
spection of the anomalous difference map, we discovered dimethylarsenic
covalently bound to several cysteine residues (Figure S2) (Dyda et al., 1994).
We took advantage of this to solve the Ab-bound structure by MR/SAD using
substrate-free hPreP as the search model and arsenic as the heavy atom
(Table 1). Phasing and refinement were performed in PHENIX. Manual
rebuilding and editing were done in COOT (Emsley and Cowtan, 2004).
MolProbity (Chen et al., 2010) was used to validate stereochemistry.
Kinetic Assays
HPreP enzymatic activity was quantified at 37C bymonitoring the cleavage of
substrate V (7-methoxycoumarin-4-yl-acetyl-RPPGFSAFK-2,4-dinitrophenyl,
R&D Systems), a fluorogenic bradykinin mimetic, at an excitation wavelength
of 327 nm and emission wavelength of 395 nm on a Tecan Safire microplate
reader. To initiate the reaction, 1 ml 1.25 mM (125 pm) of hPreP was added to
the various concentrations of substrate V in 50mMKPO4 (pH 7.3) to a final vol-
umeof 100 ml. Cleavagewas assessedbymeasuring the fluorescence increase
at 10-s intervals with 9 reads/well/time point. To determine the enzymatic
activity, background subtraction and linear regression were used (R2 cutoff =
97%). Specific activities (s1) were calculated by comparing the maximal fluo-
rescence converted from the known quantity of substrate V by hPreP.
Ab Degradation Assays
Ab digestion reactions were performed at 37C by adding 500 pmol Ab40 to
0.5–5 pmol of hPreP in a 10-ml reaction system. The reaction was quenched
immediately (1 s) by the addition of 10 ml stop solution (170 mM EDTA and
0.07% TFA). Samples were then reconstituted with 5mL 0.1% trifluoroacetic
acid (TFA) and purified over a C18 column (Millipore). For MALDI-TOF/TOF
analysis, samples were then mixed with 2.5 ml matrix (a-cyano-4hydroxycin-
namic acid) in 70%acetonitrile (ACN) and 0.1%TFA and spotted onto the plate
for data collection on an AB Sciex TOF/TOF 5800 machine in positive reflector
or linear modes over 800–6,000 mass to charge ratio (m/z) range. Data were
analyzed by MMass (Strohalm et al., 2010), fragments were matched with
FindPept using a 0.5-Da tolerance, and b/y ions were identified with a molec-
ular weight calculator. Q-TOF LC-MS/MS analysis used 1 pmol hPreP and
500 pmol Ab40. The reaction system was reconstituted with 10 ml 0.1% TFA,
analyzed on an Agilent ChipCube II (300SB C18 Zorbax, 43 mm3 75 mm inser-
tion device (ID), 5-mm particle size, 40-nl trapping column) by elution with
5–65% ACN over 8.0 min at 2.5 ml/min. Data were collected over 300–2,400
(m/z) on an Agilent 6540 Q-TOF LC-MS/MS machine in ESI+ mode and then
analyzed and deconvoluted, b/y Ions identified, and fragments matched using
a 30-ppm tolerance in MassHunter (Agilent).
SAXS Data Collection and Analysis
Data were collected at Argonne National Laboratory’s Advanced Photon
Source, beamline 18ID, at 23C using a Mar 165 charge-coupled device
(CCD) detector, an incident x-ray wavelength of 1.033 A˚, and a protein concen-
tration of 0.5 mg/ml. For Ab binding experiments, hPreP was preincubated
with a 2 molar excess of Ab40 for 20 min. Data were reduced using custom
macros for IgorPro (WaveMetrics) written by the BioCAT staff and then
analyzed using ATSAS (Petoukhov et al., 2012). We used PRIMUS and
GNOM to determine the Rg in reciprocal and real space, respectively. Theoret-
ical scattering curves were calculated for models and fit to the experimental
data using CRYSOL, and OLIGOMER was used to determine the sample’s
percent composition by conformational state.
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